Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment
Cohort-NHS
1 other identifier
observational
50
1 country
1
Brief Summary
Disease or general study area: Uncomplicated rhegmatogenous retinal detachment (RRD) and risk of proliferative vittroretinopathy (PVR) Purpose and nature of the study:
- 1.Characterise the cytokine profile of vitreous fluid in uncomplicated RRD.
- 2.Develop a risk model to predict development of PVR after retinal detachment surgery using imaging and molecular biomarkers.
- 3.To develop deep learning/artificial intelligence (AI) models for PVR detection in retinal detachment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2026
CompletedFirst Posted
Study publicly available on registry
February 4, 2026
CompletedStudy Start
First participant enrolled
April 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 27, 2027
May 6, 2026
January 1, 2026
9 months
January 27, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Characterise the cytokine milieu in an uncomplicated RRD eye.
Study cytokine profile using a multiplex assay that includes all relevant cytokines.
3 months
Secondary Outcomes (2)
Develop a risk model for development of PVR after retinal detachment surgery using imaging and molecular biomarkers.
3 months
To develop deep learning AI models for PVR detection in retinal detachment.
3 months
Eligibility Criteria
* Adults ≥18 years * Uncomplicated primary rhegmatogenous retinal detachment * Moorfields Eye Hospital
You may qualify if:
- Adults ≥18 years
- Uncomplicated primary rhegmatogenous retinal detachment
- PVD present
- No PVR-A/B/C
- Phakic or pseudophakic.
You may not qualify if:
- Patients \<18 years
- Patients lacking capacity
- Previous vitrectomy
- Previous cryopexy
- Aphakia
- No fundal view
- Diabetic retinopathy of any severity
- Retinal detachment secondary to infective causes e.g. acute retinal necrosis, toxoplasmosis scars
- Retinal detachment secondary to congenital defects e.g. optic disc pit/coloboma
- Exudative retinal detachment
- Tractional retinal detachment
- Ongoing involvement in another ocular trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moorfields Eye Hospital
London, N17 9GZ, United Kingdom
Biospecimen
Vitreous
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2026
First Posted
February 4, 2026
Study Start
April 27, 2026
Primary Completion (Estimated)
January 27, 2027
Study Completion (Estimated)
January 27, 2027
Last Updated
May 6, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
Cytokine profile